White Paper
Accelerating Generic Approvals: 5 Keys To Being First To Market
At a time when many of the most successful drugs are reaching the patent cliff, opening the floodgates for generic substitutes, generic companies are rushing to target the best candidates and enter the market first. And they are relying more heavily than ever on qualified outsource product development partners.
Competition in the generics market has never been greater. As patents on pharmaceutical products with sales of more than $267B expire over the next six years, companies worldwide are seizing the opportunity to introduce a generic alternative and rigorously competing to be first to market.
The content you requested is only available to registered users of Pharmaceutical Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
